tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Neuphoria Therapeutics Delays 10-Q Filing
PremiumCompany AnnouncementsNeuphoria Therapeutics Delays 10-Q Filing
5M ago
Neuphoria Therapeutics provides review of 2024, highlights 2025 plans
Premium
The Fly
Neuphoria Therapeutics provides review of 2024, highlights 2025 plans
6M ago
Neuphoria Therapeutics to receive $15M payment from Merck
Premium
The Fly
Neuphoria Therapeutics to receive $15M payment from Merck
8M ago
Neuphoria Therapeutics price target raised to $21 from $8 at H.C. Wainwright
PremiumThe FlyNeuphoria Therapeutics price target raised to $21 from $8 at H.C. Wainwright
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100